{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:00:54Z","timestamp":1789041654389,"version":"build-2803163510"},"reference-count":81,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Russian Federation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Adenoviral vectors (AdVs) are effective vectors for gene therapy due to their broad tropism, large capacity, and high transduction efficiency, making them widely used as oncolytic vectors and for creating vector-based vaccines. This review also considers the application of adenoviral vectors in oncolytic virotherapy and gene therapy for inherited diseases, analyzing strategies to enhance their efficacy and specificity. However, despite significant progress in this field, the use of adenoviral vectors is limited by their high immunogenicity, low specificity to certain cell types, and limited duration of transgene expression. Various strategies and technologies aimed at improving the characteristics of adenoviral vectors are being developed to overcome these limitations. Significant attention is being paid to the creation of tissue-specific promoters, which allow for the controlled expression of transgenes, as well as capsid modifications that enhance tropism to target cells, which also play a key role in reducing immunogenicity and increasing the efficiency of gene delivery. This review focuses on modern approaches to adenoviral vector modifications made to enhance their effectiveness in gene therapy, analyzing the current achievements, challenges, and prospects for applying these technologies in clinical practice, as well as identifying future research directions necessary for successful clinical implementation.<\/jats:p>","DOI":"10.3390\/ijms252212461","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T09:14:38Z","timestamp":1732094078000},"page":"12461","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Strategies for Modifying Adenoviral Vectors for Gene Therapy"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6520-3917","authenticated-orcid":false,"given":"Anna","family":"Muravyeva","sequence":"first","affiliation":[{"name":"Laboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Smirnikhina","sequence":"additional","affiliation":[{"name":"Laboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","article-title":"The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F","volume":"72","author":"Roelvink","year":"1998","journal-title":"J. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1002\/jgm.3015","article-title":"Gene Therapy Clinical Trials Worldwide to 2017: An Update","volume":"20","author":"Ginn","year":"2018","journal-title":"J. Gene Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fischer, J., Fedotova, A., B\u00fchler, C., Darriba, L., Schreiner, S., and Ruzsics, Z. (2024). Expanding the Scope of Adenoviral Vectors by Utilizing Novel Tools for Recombination and Vector Rescue. Viruses, 16.","DOI":"10.3390\/v16050658"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral Vector Vaccine Platforms in the SARS-CoV-2 Pandemic","volume":"6","author":"Lorincz","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3892\/or.2021.8000","article-title":"Oncolytic Adenovirus: A Tool for Reversing the Tumor Microenvironment and Promoting Cancer Treatment (Review)","volume":"45","author":"Wang","year":"2021","journal-title":"Oncol. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/hum.2017.218","article-title":"The First Approved Gene Therapy Product for Cancer Ad-P53 (Gendicine): 12 Years in the Clinic","volume":"29","author":"Zhang","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/1568009618666171129221503","article-title":"Oncorine, the World First Oncolytic Virus Medicine and Its Update in China","volume":"18","author":"Liang","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.3390\/cimb45060307","article-title":"Adenovirus as a Vector and Oncolytic Virus","volume":"45","author":"Matsunaga","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/gt.2009.95","article-title":"Systemic Administration of a PEGylated Adenovirus Vector with a Cancer-Specific Promoter Is Effective in a Mouse Model of Metastasis","volume":"16","author":"Yao","year":"2009","journal-title":"Gene Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0016-5085(03)01196-X","article-title":"Infectivity Enhanced, Cyclooxygenase-2 Promoter-Based Conditionally Replicative Adenovirus for Pancreatic Cancer","volume":"125","author":"Yamamoto","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_11","first-page":"49","article-title":"Targeting Cell-Specific Gene Expression with an Adenovirus Vector Containing the LacZ Gene under the Control of the CFTR Promoter","volume":"3","author":"Imler","year":"1996","journal-title":"Gene Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1525-0016(03)00059-5","article-title":"Reduced Inflammation and Improved Airway Expression Using Helper-Dependent Adenoviral Vectors with a K18 Promoter","volume":"7","author":"Toietta","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1089\/10430349950017455","article-title":"Use of a Liver-Specific Promoter Reduces Immune Response to the Transgene in Adenoviral Vectors","volume":"10","author":"Pastore","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1128\/JVI.74.6.2567-2583.2000","article-title":"Efficient Gene Transfer into Human CD34+ Cells by a Retargeted Adenovirus Vector","volume":"74","author":"Shayakhmetov","year":"2000","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101308","DOI":"10.1016\/j.omtm.2024.101308","article-title":"A Pseudotyped Adenovirus Serotype 5 Vector with Serotype 49 Fiber Knob Is an Effective Vector for Vaccine and Gene Therapy Applications","volume":"32","author":"Bliss","year":"2024","journal-title":"Mol. Ther.-Methods Clin. Dev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nemerow, G.R. (2024). Integrin-Targeting Strategies for Adenovirus Gene Therapy. Viruses, 16.","DOI":"10.3390\/v16050770"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/hum.2009.056","article-title":"Adenovirus 5\u2013Fiber 35 Chimeric Vector Mediates Efficient Apical Correction of the Cystic Fibrosis Transmembrane Conductance Regulator Defect in Cystic Fibrosis Primary Airway Epithelia","volume":"21","author":"Granio","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1128\/JVI.73.10.8689-8695.1999","article-title":"A Chimeric Type 2 Adenovirus Vector with a Type 17 Fiber Enhances Gene Transfer to Human Airway Epithelia","volume":"73","author":"Zabner","year":"1999","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virol.2004.04.001","article-title":"Adenovirus Type 5 Pseudotyped with Adenovirus Type 37 Fiber Uses Sialic Acid as a Cellular Receptor","volume":"324","author":"Cashman","year":"2004","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd4519","article-title":"Principles in the Design of Ligand-Targeted Cancer Therapeutics and Imaging Agents","volume":"14","author":"Srinivasarao","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1089\/hum.2009.190","article-title":"Targeting Adenoviruses with Factor X-Single-Chain Antibody Fusion Proteins","volume":"21","author":"Chen","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1525-0016(03)00213-2","article-title":"Metabolically Biotinylated Adenovirus for Cell Targeting, Ligand Screening, and Vector Purification","volume":"8","author":"Parrott","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1525-0016(03)00139-4","article-title":"Targeting Adenoviral Vectors Using Heterofunctional Polyethylene Glycol FGF2 Conjugates","volume":"8","author":"Lanciotti","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/1878-0261.13648","article-title":"Oncolytic Adenoviruses and Immunopeptidomics: A Convenient Marriage","volume":"18","author":"Gillard","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7056","DOI":"10.1038\/s41467-023-42668-7","article-title":"Development of Mesothelioma-Specific Oncolytic Immunotherapy Enabled by Immunopeptidomics of Murine and Human Mesothelioma Tumors","volume":"14","author":"Chiaro","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Feola, S., Russo, S., Martins, B., Lopes, A., Vandermeulen, G., Fluhler, V., De Giorgi, C., Fusciello, M., Pesonen, S., and Yl\u00f6sm\u00e4ki, E. (2022). Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.826164"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Peltonen, K., Feola, S., Umer, H.M., Chiaro, J., Mermelekas, G., Yl\u00f6sm\u00e4ki, E., Pesonen, S., Branca, R.M.M., Lehti\u00f6, J., and Cerullo, V. (2021). Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy. Cancers, 13.","DOI":"10.3390\/cancers13143408"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e71156","DOI":"10.7554\/eLife.71156","article-title":"A Novel Immunopeptidomic-Based Pipeline for the Generation of Personalized Oncolytic Cancer Vaccines","volume":"11","author":"Feola","year":"2022","journal-title":"Elife"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1172\/JCI8858","article-title":"Targeting the Urokinase Plasminogen Activator Receptor Enhances Gene Transfer to Human Airway Epithelia","volume":"105","author":"Drapkin","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1172\/JCI5309","article-title":"CAR-Dependent and CAR-Independent Pathways of Adenovirus Vector-Mediated Gene Transfer and Expression in Human Fibroblasts","volume":"103","author":"Hidaka","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1128\/JVI.76.7.3452-3460.2002","article-title":"Adenovirus Binding to the Coxsackievirus and Adenovirus Receptor or Integrins Is Not Required To Elicit Brain Inflammation but Is Necessary To Transduce Specific Neural Cell Types","volume":"76","author":"Thomas","year":"2002","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ymthe.2004.02.006","article-title":"Enhanced Gene Transfer to Mouse Dendritic Cells Using Adenoviral Vectors Coated with a Novel Adapter Molecule","volume":"9","author":"Pereboev","year":"2004","journal-title":"Mol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1158\/0008-5472.CAN-06-4679","article-title":"Adenovirus Tumor Targeting and Hepatic Untargeting by a Coxsackie\/Adenovirus Receptor Ectodomain Anti-Carcinoembryonic Antigen Bispecific Adapter","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrg2141","article-title":"Engineering Targeted Viral Vectors for Gene Therapy","volume":"8","author":"Waehler","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm0396-299","article-title":"Toward Cell-Targeting Gene Therapy Vectors: Selection of Cell-Binding Peptides from Random Peptide-Presenting Phage Libraries","volume":"2","author":"Barry","year":"1996","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13667","DOI":"10.1128\/JVI.79.21.13667-13672.2005","article-title":"Selection of Muscle-Binding Peptides from Context-Specific Peptide-Presenting Phage Libraries for Adenoviral Vector Targeting","volume":"79","author":"Ghosh","year":"2005","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1182\/blood.V106.11.5534.5534","article-title":"Dexamethasone Promotes Transgene Expression and Supresses the Early Immune \/Inflammatory Response in Adenovirus- Mediated Gene Delivery to Hemophilic Mice","volume":"106","author":"Othman","year":"2005","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/microbiolres15030105","article-title":"Effects of Common Anti-Inflammatories on Adenovirus Entry and Their Physicochemical Properties: An In-Depth Study Using Cellular and Animal Models","volume":"15","year":"2024","journal-title":"Microbiol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/00016480410018160","article-title":"Suppression of Inflammation by Dexamethasone Prolongs Adenoviral Vector-Mediated Transgene Expression in Murine Nasal Mucosa","volume":"125","author":"Kumahara","year":"2005","journal-title":"Acta Otolaryngol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/mto.2015.21","article-title":"Evaluation of Polymer Shielding for Adenovirus Serotype 6 (Ad6) for Systemic Virotherapy against Human Prostate Cancers","volume":"3","author":"Nguyen","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/138920106777950852","article-title":"Novel Delivery Technologies for Protein and Peptide Therapeutics","volume":"7","author":"Soppimath","year":"2006","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003088-200645100-00002","article-title":"Nanomedicine: Clinical Applications of Polyethylene Glycol Conjugated Proteins and Drugs","volume":"45","author":"Parveen","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/10428190601175393","article-title":"Phase II, Randomized, Multicenter, Comparative Study of Peginterferon-Alpha-2a (40 KD) (Pegasys) versus Interferon Alpha-2a (Roferon-A) in Patients with Treatment-Na\u00efve, Chronic-Phase Chronic Myelogenous Leukemia","volume":"48","author":"Lipton","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/0-306-47932-X_3","article-title":"PEG-Adenosine Deaminase and PEG-Asparaginase","volume":"519","author":"Davis","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of Adenovirus with Retention of Infectivity and Protection from Neutralizing Antibody in Vitro and in Vivo","volume":"10","author":"Lachapelle","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jgm.699","article-title":"PEGylated Adenovirus Vectors Containing RGD Peptides on the Tip of PEG Show High Transduction Efficiency and Antibody Evasion Ability","volume":"7","author":"Eto","year":"2005","journal-title":"J. Gene Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.75.10.4792-4801.2001","article-title":"\u201cStealth\u201d Adenoviruses Blunt Cell-Mediated and Humoral Immune Responses against the Virus and Allow for Significant Gene Expression upon Readministration in the Lung","volume":"75","author":"Croyle","year":"2001","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.gt.3301389","article-title":"Polymer-Coated Adenovirus Permits Efficient Retargeting and Evades Neutralising Antibodies","volume":"8","author":"Fisher","year":"2001","journal-title":"Gene Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"101286","DOI":"10.1016\/j.omtm.2024.101286","article-title":"Evaluation of Anti-Vector Immune Responses to Adenovirus-Mediated Lung Gene Therapy and Modulation by ACD20","volume":"32","author":"Clark","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14161","DOI":"10.1128\/JVI.79.22.14161-14168.2005","article-title":"Immunogenicity of Recombinant Fiber-Chimeric Adenovirus Serotype 35 Vector-Based Vaccines in Mice and Rhesus Monkeys","volume":"79","author":"Nanda","year":"2005","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gt.2010.37","article-title":"Influence of Chimeric Human-Bovine Fibers on Adenoviral Uptake by Liver Cells and the Antiviral Immune Response","volume":"17","author":"Grellier","year":"2010","journal-title":"Gene Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1073\/pnas.95.14.7866","article-title":"An Adenoviral Vector Deleted for All Viral Coding Sequences Results in Enhanced Safety and Extended Expression of a Leptin Transgene","volume":"95","author":"Morsy","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0298-180","article-title":"Genomic DNA Transfer with a High-Capacity Adenovirus Vector Results in Improved in Vivo Gene Expression and Decreased Toxicity","volume":"18","author":"Schiedner","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1089\/hum.1998.9.18-2709","article-title":"High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of Alpha1-Antitrypsin with Negligible Toxicity","volume":"9","author":"Morral","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1073\/pnas.96.22.12816","article-title":"Administration of Helper-Dependent Adenoviral Vectors and Sequential Delivery of Different Vector Serotype for Long-Term Liver-Directed Gene Transfer in Baboons","volume":"96","author":"Morral","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2003-05-1426","article-title":"Helper-Dependent Adenoviral Vectors Mediate Therapeutic Factor VIII Expression for Several Months with Minimal Accompanying Toxicity in a Canine Model of Severe Hemophilia A","volume":"103","author":"Brown","year":"2004","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/hum.2005.16.811","article-title":"Sustained Phenotypic Correction of Canine Hemophilia B after Systemic Administration of Helper-Dependent Adenoviral Vector","volume":"16","author":"Nichols","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1073\/pnas.0500930102","article-title":"Lifelong Elimination of Hyperbilirubinemia in the Gunn Rat with a Single Injection of Helper-Dependent Adenoviral Vector","volume":"102","author":"Toietta","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1073\/pnas.241506298","article-title":"Lifetime Correction of Genetic Deficiency in Mice with a Single Injection of Helper-Dependent Adenoviral Vector","volume":"98","author":"Kim","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.4049\/jimmunol.169.8.4651","article-title":"Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses","volume":"169","author":"Roth","year":"2002","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1128\/JVI.78.11.5966-5972.2004","article-title":"Helper-Dependent Adenovirus Vectors Elicit Intact Innate but Attenuated Adaptive Host Immune Responses in Vivo","volume":"78","author":"Muruve","year":"2004","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bandara, R.A., Chen, Z.R., and Hu, J. (2021). Potential of Helper-Dependent Adenoviral Vectors in CRISPR-Cas9-Mediated Lung Gene Therapy. Cell Biosci., 11.","DOI":"10.1186\/s13578-021-00662-w"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Cao, H., Duan, R., and Hu, J. (2020). Overcoming Immunological Challenges to Helper-Dependent Adenoviral Vector-Mediated Long-Term CFTR Expression in Mouse Airways. Genes, 11.","DOI":"10.3390\/genes11050565"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-Penetrating Nanoparticles for Drug and Gene Delivery to Mucosal Tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1128\/JVI.72.7.6014-6023.1998","article-title":"Limited Entry of Adenovirus Vectors into Well-Differentiated Airway Epithelium Is Responsible for Inefficient Gene Transfer","volume":"72","author":"Pickles","year":"1998","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/jgm.797","article-title":"Aerosol Delivery of an Enhanced Helper-Dependent Adenovirus Formulation to Rabbit Lung Using an Intratracheal Catheter","volume":"7","author":"Koehler","year":"2005","journal-title":"J. Gene Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/104303401300042348","article-title":"EGTA Enhancement of Adenovirus-Mediated Gene Transfer to Mouse Tracheal Epithelium in Vivo","volume":"12","author":"Chu","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1089\/hum.1998.9.18-2661","article-title":"Enhanced in Vivo Airway Gene Transfer via Transient Modification of Host Barrier Properties with a Surface-Active Agent","volume":"9","author":"Parsons","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/104303403765255138","article-title":"Safety and Efficiency of Modulating Paracellular Permeability to Enhance Airway Epithelial Gene Transfer in Vivo","volume":"14","author":"Johnson","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1165\/ajrcmb.22.2.3938","article-title":"Increasing Epithelial Junction Permeability Enhances Gene Transfer to Airway Epithelia In Vivo","volume":"22","author":"Wang","year":"2000","journal-title":"Rapid Commun. Am. J. Respir. Cell Mol. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/10430349950018670","article-title":"Delivery of an Adenovirus Vector in a Calcium Phosphate Coprecipitate Enhances the Therapeutic Index of Gene Transfer to Airway Epithelia","volume":"10","author":"Lee","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1089\/hum.1998.9.10-1469","article-title":"Potentiation of Gene Transfer to the Mouse Lung by Complexes of Adenovirus Vector and Polycations Improves Therapeutic Potential","volume":"9","author":"Kaplan","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.gt.3302712","article-title":"Readministration of Helper-Dependent Adenovirus to Mouse Lung","volume":"13","author":"Koehler","year":"2006","journal-title":"Gene Ther."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"(2005). 815. Aerosol Delivery of Helper-Dependent Adenoviral Vector into Nonhuman Primate Lungs Results in High Efficiency Pulmonary Transduction with Minimal Toxicity. Mol. Ther., 11, S317.","DOI":"10.1016\/j.ymthe.2005.07.352"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/humc.2014.154","article-title":"Ferret and Pig Models of Cystic Fibrosis: Prospects and Promise for Gene Therapy","volume":"26","author":"Yan","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/hum.2017.201","article-title":"Transducing Airway Basal Cells with a Helper-Dependent Adenoviral Vector for Lung Gene Therapy","volume":"29","author":"Cao","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1038\/mtna.2013.55","article-title":"Efficient Gene Delivery to Pig Airway Epithelia and Submucosal Glands Using Helper-Dependent Adenoviral Vectors","volume":"2","author":"Cao","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1525-0016(02)00021-7","article-title":"Enhancement of Adenovirus-Mediated Gene Transfer to the Airways by DEAE Dextran and Sodium Caprate In Vivo","volume":"7","author":"Grogory","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(84)90265-4","article-title":"Aerosol EDTA to Eliminate Respiratory-Tract Pseudomonas","volume":"2","author":"Hillman","year":"1984","journal-title":"Lancet"},{"key":"ref_80","unstructured":"George, T., and Brady, M.F. (2023). Ethylenediaminetetraacetic Acid (EDTA). The 100 Most Important Chemical Compounds, Statpearls Publishing."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/hum.2009.035","article-title":"Developing Cell Therapy Techniques for Respiratory Disease: Intratracheal Delivery of Genetically Engineered Stem Cells in a Murine Model of Airway Injury","volume":"20","author":"Leblond","year":"2009","journal-title":"Hum. Gene Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12461\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:36:03Z","timestamp":1760114163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":81,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252212461"],"URL":"https:\/\/doi.org\/10.3390\/ijms252212461","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}